Hutchison China MediTech Ltd ADR buy melinda
Start price
12.03.18
/
50%
€33.42
Target price
12.09.18
€40.59
Performance (%)
-26.30%
End price
12.09.18
€24.63
Summary
This prediction ended on 12.09.18 with a price of €24.63. The price of Hutchison China MediTech Ltd ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.30%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | -4.000% | -4.000% | -23.567% | -18.367% |
| iShares Core DAX® | -0.383% | 1.093% | 11.642% | 60.422% |
| iShares Nasdaq 100 | -0.411% | -1.973% | 7.273% | 87.823% |
| iShares Nikkei 225® | 1.838% | 10.261% | 31.381% | 66.929% |
| iShares S&P 500 | -0.712% | 0.445% | 4.295% | 60.457% |
Comments by melinda for this prediction
In the thread Hutchison China MediTech Ltd ADR diskutieren
Pharmazeutische SecteurProduits Agenda 12/03 | 08.00 Uhr veröffentlichte Ergebnisse
Hutchison China Meditech wendet sich an die erste Arzneimittelzulassung in diesem Jahr
(Laufzeit überschritten)